Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
editorial
. 1993 Feb 20;306(6876):469–470. doi: 10.1136/bmj.306.6876.469

Managing chronic hepatitis C virus infection.

J Y Lau, G L Davis
PMCID: PMC1676809  PMID: 7680588

Full text

PDF
469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti A., Morsica G., Chemello L., Cavalletto D., Noventa F., Pontisso P., Ruol A. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet. 1992 Sep 19;340(8821):697–698. doi: 10.1016/0140-6736(92)92234-7. [DOI] [PubMed] [Google Scholar]
  2. Boyer N., Marcellin P., Degott C., Degos F., Saimot A. G., Erlinger S., Benhamou J. P. Recombinant interferon-alpha for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. Comité des Anti-Viraux. J Infect Dis. 1992 Apr;165(4):723–726. doi: 10.1093/infdis/165.4.723. [DOI] [PubMed] [Google Scholar]
  3. Colombo M., Kuo G., Choo Q. L., Donato M. F., Del Ninno E., Tommasini M. A., Dioguardi N., Houghton M. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet. 1989 Oct 28;2(8670):1006–1008. doi: 10.1016/s0140-6736(89)91016-7. [DOI] [PubMed] [Google Scholar]
  4. Durand J. M., Kaplanski G., Lefevre P., Richard M. A., Andrac L., Trepo C., Soubeyrand J. Effect of interferon-alpha 2b on cryoglobulinemia related to hepatitis C virus infection. J Infect Dis. 1992 Apr;165(4):778–779. doi: 10.1093/infdis/165.4.778. [DOI] [PubMed] [Google Scholar]
  5. Farci P., Alter H. J., Wong D., Miller R. H., Shih J. W., Jett B., Purcell R. H. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med. 1991 Jul 11;325(2):98–104. doi: 10.1056/NEJM199107113250205. [DOI] [PubMed] [Google Scholar]
  6. Reichard O., Andersson J., Schvarcz R., Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet. 1991 May 4;337(8749):1058–1061. doi: 10.1016/0140-6736(91)91707-2. [DOI] [PubMed] [Google Scholar]
  7. Tinè F., Magrin S., Craxì A., Pagliaro L. Interferon for non-A, non-B chronic hepatitis. A meta-analysis of randomised clinical trials. J Hepatol. 1991 Sep;13(2):192–199. doi: 10.1016/0168-8278(91)90814-r. [DOI] [PubMed] [Google Scholar]
  8. Van der Poel C. L., Cuypers H. T., Reesink H. W., Weiner A. J., Quan S., Di Nello R., Van Boven J. J., Winkel I., Mulder-Folkerts D., Exel-Oehlers P. J. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 1991 Feb 9;337(8737):317–319. doi: 10.1016/0140-6736(91)90942-i. [DOI] [PubMed] [Google Scholar]
  9. Wang J. T., Wang T. H., Lin J. T., Sheu J. C., Lee C. Z., Chen D. S. Improved serodiagnosis of posttransfusion hepatitis C virus infection by a second-generation immunoassay based on multiple recombinant antigens. Vox Sang. 1992;62(1):21–24. doi: 10.1111/j.1423-0410.1992.tb01161.x. [DOI] [PubMed] [Google Scholar]
  10. Yoshizawa H., Nojiri N., Takahashi K. Measurement of anti-GOR antibodies in prevention of post-transfusion non-A, non-B hepatitis. Lancet. 1991 Jan 5;337(8732):47–48. doi: 10.1016/0140-6736(91)93364-f. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES